Functional Analysis of Genetic Variation in Catechol-O-Methyltransferase (COMT): Effects on mRNA, Protein, and Enzyme Activity in Postmortem Human Brain
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Catechol-O-methyltransferase (COMT) is a key enzyme in the elimination of dopamine in the prefrontal cortex of the human brain. Genetic variation in the COMT gene (MIM 116790) has been associated with altered prefrontal cortex function and higher risk for schizophrenia, but the specific alleles and their functional implications have been controversial. We analyzed the effects of several single-nucleotide polymorphisms (SNPs) within COMT on mRNA expression levels (using reverse-transcriptase polymerase chain reaction analysis), protein levels (using Western blot analysis), and enzyme activity (using catechol methylation) in a large sample (n = 108) of postmortem human prefrontal cortex tissue, which predominantly expresses the -membrane-bound isoform. A common coding SNP, Val158Met (rs4680), significantly affected protein abundance and enzyme activity but not mRNA expression levels, suggesting that differences in protein integrity account for the difference in enzyme activity between alleles. A SNP in intron 1 (rs737865) and a SNP in the 3' flanking region (rs165599)--both of which have been reported to contribute to allelic expression differences and to be associated with schizophrenia as part of a haplotype with Val--had no effect on mRNA expression levels, protein immunoreactivity, or enzyme activity. In lymphocytes from 47 subjects, we confirmed a similar effect on enzyme activity in samples with the Val/Met genotype but no effect in samples with the intron 1 or 3' SNPs. Separate analyses revealed that the subject's sex, as well as the presence of a SNP in the P2 promoter region (rs2097603), had small effects on COMT enzyme activity. Using site-directed mutagenesis of mouse COMT cDNA, followed by in vitro translation, we found that the conversion of Leu at the homologous position into Met or Val progressively and significantly diminished enzyme activity. Thus, although we cannot exclude a more complex genetic basis for functional effects of COMT, Val is a predominant factor that determines higher COMT activity in the prefrontal cortex, which presumably leads to lower synaptic dopamine levels and relatively deleterious prefrontal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A polymorphism of COMT with decreased function (Chen et al., 2004), was associated with increased activation of the IFG during action cancelation (Congdon et al., 2009) and decreased interference inhibition (Solis-Ortiz et al., 2010), although conflicting results have also been reported (Kramer et al., 2007).”
From Response Inhibition and Interference Control in Obsessive–Compulsive Spectrum Disorders (2014) · cites this paper as Chen et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“The COMT enzyme plays a significant role in regulating frontal DA (Chen et al., 2004)”
From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Chen et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“The common rs4680 Val 158 Met single nucleotide polymorphism (SNP) leads to a reduction of COMT enzymatic activity in Met carriers (6-8).”
From Influence of the COMT genotype on working memory and brain activity changes during development (2011) · cites this paper as [6]
In the citing paper
“The COMT val allele is associated with high enzymatic activity and consequently low synaptic dopamine levels, whereas the COMT met allele results in approximately one third less enzyme activity and consequently high synaptic dopamine (Chen, Lipska et al. 2004).”
From Developmental imaging genetics: Linking dopamine function to adolescent behavior (2014) · cites this paper as Chen, Lipska et al. 2004
In the citing paper
“which are responsible for the bulk of dopamine degradation in the striatum and the prefrontal cortex respectively”
From DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls (2010) · cites this paper as Chen et al, 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Self-citationSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Self-citationEnzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283 · cited 1×
“Since its discovery in 1958 (Axelrod and Tomchick 1958), catechol-O-methyltransferase (COMT) has been an important enzyme in catecholamine biochemistry and pharmacology and, more recently, in genetic mechanisms of variation in catechol metabolism and its clinical implications.”
BackgroundLotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., & Taskinen, J. (1995) · Biochemistry · doi:10.1021/bi00013a008 · Cited by 1,167
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893 · cited 1×
“Indeed, clinical studies of COMT have revealed that the Met allele, which encodes the enzyme with lower activity, is associated with better performance on tests of prefrontally mediated cognition (Egan et al. 2001; Goldberg et al. 2003; Mattay et al. 2003; Diamond et al. 2004; Nolan et al. 2004).”
BackgroundSelf-citationGogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Self-citation
Cited by
Items 401–500 of 1,003
Meta-Analysis of the COMT Val158Met Polymorphism in Major Depressive Disorder: Effect of Ethnicity
Wang, M., Ma, Y., Yuan, W., Su, K., & Li, M. D. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9651-3 · Cited by 55
Systematic review and meta-analysis of genetic studies of late-life depression
Tsang, R. S. M., Mather, K. A., Sachdev, P. S., & Reppermund, S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.028 · Cited by 54
Genetically determined dopamine availability predicts disposition for depression
Felten, A., Montag, C., Markett, S., Walter, N. T., & Reuter, M. (2011) · Brain and Behavior · doi:10.1002/brb3.20 · Cited by 54
Mouse models of gene–environment interactions in schizophrenia
Kannan, G., Sawa, A., & Pletnikov, M. V. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.05.012 · Cited by 52
van den Bos, R., Homberg, J. R., Gijsbers, E., den Heijer, E., & Cuppen, E. P. J. G. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.10.002 · Cited by 54
Wardle, M. C., de Wit, H., Penton-Voak, I., Lewis, G., & Munafò, M. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.24 · Cited by 51
Expression of multiple catechol‐o‐methyltransferase (COMT) mRNA variants in human brain
Tunbridge, E. M., Lane, T. A., & Harrison, P. J. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30539 · Cited by 54
Zhang, Z., Lindpaintner, K., Che, R., He, Z., Wang, P., Yang, P., Feng, G., He, L., & Shi, Y. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0260-7 · Cited by 54
Gene–gene interaction between MAOA and COMT in suicidal behavior: Analysis in schizophrenia
Luca, V. D., Tharmalingam, S., Müller, D. J., Wong, G., de Bartolomeis, A., & Kennedy, J. L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.053 · Cited by 54
Yacubian, J., & Büchel, C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.015 · Cited by 53
Michaelovsky, E., Gothelf, D., Korostishevsky, M., Frisch, A., Burg, M., Carmel, M., Steinberg, T., Inbar, D., Apter, A., & Weizman, A. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008085 · Cited by 53
“The 158Met variant of the membranebound enzyme (MB-COMT) has substantially lower enzymatic activity in the brain compared to the 158Val allele (Chen et al., 2004), thus these variants are often referred to as COMT high- and low-activity alleles.”
BackgroundCOMT and ANKK1-Taq-Ia Genetic Polymorphisms Influence Visual Working Memory
Berryhill, M. E., Wiener, M., Stephens, J. A., Lohoff, F. W., & Coslett, H. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055862 · Cited by 53
Li, X., He, X., Chen, S., Le, Y., Bryant, M., Guo, L., Witt, K. L., & Mei, N. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.03.006 · Cited by 53
Ruyck, K. D., Nackaerts, K., Beels, L., Werbrouck, J., Volder, A. D., Meysman, M., Salhi, B., van Meerbeeck, J. P., & Thierens, H. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.75 · Cited by 53
Tunbridge, E. M., Harrison, P. J., Warden, D. R., Johnston, C., Refsum, H., & Smith, A. D. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30700 · Cited by 53
Winkler, E. A., Yue, J. K., Ferguson, A. R., Temkin, N. R., Stein, M. B., Barber, J., Yuh, E. L., Sharma, S., Satris, G. G., McAllister, T. W., et al. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2016.09.017 · Cited by 52
Genetic Modulation of Transcranial Direct Current Stimulation Effects on Cognition
Wiegand, A., Nieratschker, V., & Plewnia, C. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00651 · Cited by 52
Individual predictors of sensorimotor adaptability
Seidler, R. D., Mulavara, A. P., Bloomberg, J. J., & Peters, B. T. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00100 · Cited by 53
Rasch, B., Spalek, K., Buholzer, S., Luechinger, R., Boesiger, P., de Quervain, D. J. ‐., & Papassotiropoulos, A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.05.054 · Cited by 52
Generation and Characterization of Humanized Mice Carrying COMT158 Met/Val Alleles
Risbrough, V., Ji, B., Hauger, R., & Zhou, X.-J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.29 · Cited by 47
Schellekens, A., Franke, B., Ellenbroek, B. A., Cools, A. R., de Jong, C. A. J., Buitelaar, J. K., & Verkes, R. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00438.x · Cited by 52
Różycka, A., Słopień, R., Słopień, A., Dorszewska, J., Seremak‐Mrozikiewicz, A., Lianeri, M., Maciukiewicz, M., Warenik-Szymankiewicz, A., Grzelak, T., Kurzawińska, G., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.10.011 · Cited by 53
Clinical and genetic factors associated with suicide in mood disorder patients
Antypa, N., Souery, D., Tomasini, M., Albani, D., Fusco, F., Mendlewicz, J., & Serretti, A. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0658-1 · Cited by 52
Adverse childhood experiences influence white matter microstructure in patients with schizophrenia
Poletti, S., Mazza, E. B., Bollettini, I., Locatelli, C., Cavallaro, R., Smeraldi, E., & Benedetti, F. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.08.003 · Cited by 52
Pourcain, B. S., Moskvina, V., Kirov, G., Murphy, K. C., Williams, H. J., Williams, N. M., Owen, M. J., & O’Donovan, M. C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.024 · Cited by 52
Minzenberg, M. J., Xu, K., Mitropoulou, V., Harvey, P. D., Finch, T., Flory, J. D., New, A. S., Goldman, D., & Siever, L. J. (2006) · Psychiatric Genetics · doi:10.1097/01.ypg.0000199448.00163.e6 · Cited by 45
Differential effects of COMT on gait and executive control in aging
Holtzer, R., Ozelius, L. J., Xue, X., Wang, T. C., Lipton, R. B., & Verghese, J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.011 · Cited by 52
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II
Schmitt, A., Bauer, M., Heinsen, H., Feiden, W., Falkai, P., Alafuzoff, I. I., Arzberger, T., Al‐Sarraj, S., Bell, J. E., Bogdanović, N., et al. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0601-8 · Cited by 52
Benedetti, F., Dallaspezia, S., Colombo, C., Lorenzi, C., Pirovano, A., & Smeraldi, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.01.005 · Cited by 51
Li, Z., Mulligan, M. K., Wang, X., Miles, M. F., Lu, L., & Williams, R. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012181 · Cited by 49
Cortical dopamine release during a behavioral response inhibition task
Albrecht, D., Kareken, D. A., Christian, B. T., Džemidžić, M., & Yoder, K. K. (2014) · Synapse · doi:10.1002/syn.21736 · Cited by 51
Wang, P., Xia, Y., Zou, L., Qian, X., Dou, T., Jin, Q., Li, S., Yu, Y., Wang, D., Luo, Q., et al. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701384 · Cited by 51
Hashimoto, R., Noguchi, H., Hori, H., Ohi, K., Yasuda, Y., Takeda, M., & Kunugi, H. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.036 · Cited by 51
Guo, S., Chen, D. F., Zhou, D. F., Sun, H. Q., Wu, G. Y., Haile, C. N., Kosten, T. A., Kosten, T. R., & Zhang, X. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0628-4 · Cited by 51
Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease
Fallon, S. J., Smulders, K., Esselink, R. A. J., van de Warrenburg, B. P. C., Bloem, B. R., & Cools, R. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.07.031 · Cited by 50
Nobile, M., Rusconi, M., Bellina, M., Marino, C., Giorda, R., Carlet, O., Vanzin, L., Molteni, M., & Battaglia, M. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0080-1 · Cited by 50
Effects of Modafinil on the Sleep EEG Depend on Val158Met Genotype of COMT
Bodenmann, S., & Landolt, H.-P. (2010) · Sleep · doi:10.1093/sleep/33.8.1027 · Cited by 49
Bolton, J. L., Marioni, R. E., Deary, I. J., Harris, S. E., Stewart, M. C. W., Murray, G. D., Fowkes, F. G. R., & Price, J. F. (2010) · Behavior Genetics · doi:10.1007/s10519-010-9372-y · Cited by 50
Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeutics
Diaz-Asper, C. M., Weinberger, D. R., & Goldberg, T. E. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.010 · Cited by 50
Self-citationOpgen‐Rhein, C., Neuhaus, A. H., Urbanek, C., Hahn, E. W., Sander, T., & Dettling, M. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm155 · Cited by 50
DNA Methylation in Schizophrenia Subjects: Gender and MTHFR 677C/T Genotype Differences
Burghardt, K. J., Pilsner, J. R., Bly, M. J., & Ellingrod, V. L. (2012) · Epigenomics · doi:10.2217/epi.12.25 · Cited by 49
A Preliminary Investigation of Genetic Variants Linked to Aripiprazole-Induced Adverse Effects
Guzek, K., Stelmach, A., Rożnowska, A., Najbar, I., Cichocki, Ł., & Sadakierska−Chudy, A. (2023) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/zt28xcs95j · Cited by 49
Zarchi, O., Carmel, M., Avni, C., Attias, J., Frisch, A., Michaelovsky, E., Patya, M., Green, T., Weinberger, R., Weizman, A., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.004 · Cited by 49
Lack of Association of Alcohol Dependence and Habitual Smoking With Catechol‐O‐methyltransferase
Foroud, T., Wetherill, L. F., Dick, D. M., Hesselbrock, V., Nurnberger, Jr., Kramer, J., Tischfield, J., Schuckit, M., Bierut, L. J., Xuei, X., et al. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00505.x · Cited by 47
Mikołajczyk, E., Grzywacz, A., & Samochowiec, J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.10.035 · Cited by 49
Clark, R., DeYoung, C. G., Sponheim, S. R., Bender, T. L., Polusny, M. A., Erbes, C. R., & Arbisi, P. A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.08.013 · Cited by 48
After the Honeymoon: Neural and Genetic Correlates of Romantic Love in Newlywed Marriages
Acevedo, B. P., Poulin, M. J., Collins, N. L., & Brown, L. L. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00634 · Cited by 49
COMT Val158Met and cognition: main effects and interaction with educational attainment
Enoch, M., Waheed, J., Harris, C. R., Albaugh, B., & Goldman, D. A. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00441.x · Cited by 49
Association of COMT and COMT-DRD2 interaction with creative potential
Zhang, S., Zhang, M., & Zhang, J. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00216 · Cited by 48
Wirgenes, K. V., Djurovic, S., Sundet, K. S., Agartz, I., Mattingsdal, M., Athanasiu, L., Melle, I. S., & Andreassen, O. A. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.007 · Cited by 48
Laet, S. D., Colpin, H., Leeuwen, K. G. V., Noortgate, W. V. D., Claes, S. J., Janssens, A., Goossens, L., & Verschueren, K. (2016) · Journal of Youth and Adolescence · doi:10.1007/s10964-016-0466-6 · Cited by 48
Ascorbic acid metabolites are involved in intraocular pressure control in the general population
Hysi, P. G., Khawaja, A. P., Menni, C., Tamraz, B., Wareham, N. J., Khaw, K., Foster, P. J., Benet, L. Z., Spector, T. D., & Hammond, C. J. (2018) · Redox Biology · doi:10.1016/j.redox.2018.10.004 · Cited by 48
Carpentier, P. J., Vásquez, A. A., Hoogman, M., Onnink, A. M. H., Kan, C. C., Kooij, J. J. S., Makkinje, R. R., Iskandar, S., Kiemeney, L. A. L. M., de Jong, C. A. J., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.003 · Cited by 48
Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine
Aronica, L., Ordovás, J. M., Volkov, A., Lamb, J. J., Stone, P. M., Minich, D. M., Leary, M., Class, M., Metti, D., Larson, I. A., et al. (2022) · Nutrients · doi:10.3390/nu14040768 · Cited by 47
Cannabis Pharmacogenomics: A Path to Personalized Medicine
Babayeva, M., & Loewy, Z. G. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040228 · Cited by 47
Noohi, F., Boyden, N. B., Kwak, Y., Humfleet, J., Burke, D., Müller, M. L. T. M., Bohnen, N. I., & Seidler, R. D. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00457.2013 · Cited by 47
Adrenergic signalling in osteoarthritis.
Sohn, R., Rösch, G., Junker, M., Meurer, A., Zaucke, F., & Jenei-Lanzl, Z. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109948 · Cited by 40
Valomon, A., Holst, S. C., Bachmann, V., Viola, A., Schmidt, C., Zuercher, J., Berger, W., Cajochen, C., & Landolt, H. (2014) · Chronobiology International · doi:10.3109/07420528.2014.896376 · Cited by 47
Lafuente, A., Bernardo, M., Mas, S., Crescenti, A., Aparici, M., Gassó, P., Deulofeu, R., Mané, A., Catalán, R., & Carné, X. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.08.002 · Cited by 47
Huuhka, K., Anttila, S. A. K., Huuhka, M., Hietala, J. A., Huhtala, H., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.015 · Cited by 47
Reuter, M., Esslinger, C., Montag, C., Lis, S., Gallhofer, B., & Kirsch, P. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2007.12.002 · Cited by 47
22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis
Squarcione, C., Torti, M. C., Di Fabio, F., & Biondi, M. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s52188 · Cited by 46
5.4 Dopaminergic Modulation of Flexible Cognitive Control in Humans
Cools, R., & D’Esposito, M. (2009) · Dopamine Handbook · doi:10.1093/acprof:oso/9780195373035.003.0017 · Cited by 46
Kapellou, A., King, A., Graham, C., Pilić, L., & Mavrommatis, Y. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad029 · Cited by 46
Katerberg, H., Cath, D. C., Denys, D. A. J. P., Heutink, P., Polman, A., van Nieuwerburgh, F. C. W., Deforce, D. L. D., Bochdanovits, Z., van Balkom, A. J. L. M., & den Boer, J. A. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30971 · Cited by 36
Nicotine abstinence-induced cerebral blood flow changes by genotype
Wang, Z., Ray, R., Faith, M. S., Tang, K. Z., Wileyto, E. P., Detre, J. A., & Lerman, C. E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.084 · Cited by 46
COMT × DRD4 Epistasis Impacts Prefrontal Cortex Function Underlying Response Control
Heinzel, S., Dresler, T., Baehne, C. G., Heine, M., Boreatti‐Hümmer, A., Jacob, C., Renner, T., Reif, A., Lesch, K., Fallgatter, A. J., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs132 · Cited by 46
Batalla, A., Soriano‐Mas, C., López‐Solà, M., Torrens, M., Crippa, J. A., Bhattacharyya, S., Blanco‐Hinojo, L., Fagundo, A. B., Harrison, B. J., Nogué, S., et al. (2014) · Addiction Biology · doi:10.1111/adb.12027 · Cited by 37
Tomlinson, A., Grayson, B., Marsh, S., Hayward, A., Marshall, K., & Neill, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.016 · Cited by 40
Tunbridge, E. M., Weinberger, D. R., & Harrison, P. J. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001767 · Cited by 46
Self-citationthe TRACK-TBI Investigators, Winkler, E. A., Yue, J. K., McAllister, T. W., Temkin, N. R., Oh, S. S., Burchard, E. G., Hu, D., Ferguson, A. R., Lingsma, H. F., et al. (2015) · Neurogenetics · doi:10.1007/s10048-015-0467-8 · Cited by 45
A dynamic attentional control framework for understanding sleep deprivation effects on cognition
Whitney, P. J., Hinson, J. M., & Nusbaum, A. T. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.015 · Cited by 45
Miller, R. J., Jackson, K. G., Dadd, T., Mayes, A. E., Brown, A. L., Lovegrove, J. A., & Minihane, A. M. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100726 · Cited by 45
Omair, A., Lie, B. A., Reikerås, O., Holden, M., & Brox, J. I. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-76 · Cited by 45
Sundram, F., Campbell, L., Azuma, R., Daly, E., Bloemen, O., Barker, G. J., Chitnis, X. A., Jones, D. K., van Amelsvoort, T., Murphy, K. C., et al. (2010) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9043-6 · Cited by 45
Pharmacogenetics of smoking cessation therapy
Kortmann, G. L., Dobler, C. J., Bizarro, L., & Bau, C. H. D. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30978 · Cited by 45
Ullsperger, M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.009 · Cited by 46
Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder
Grassi, G., Cecchelli, C., Vignozzi, L., & Pacini, S. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s255375 · Cited by 44
Xu, Q., Wu, X. L., Li, M., Huang, H., Minică, C. C., Yi, Z., Wang, G., Shen, L., Xing, Q., Shi, Y., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.61 · Cited by 44
COMT Val158Met polymorphism, verbalizing of emotion and activation of affective brain systems
Swart, M., Bruggeman, R., Larøi, F., Alizadeh, B. Z., Kema, I., Kortekaas, R., Wiersma, D., & Aleman, A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.12.017 · Cited by 44
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis
Chana, G., Bousman, C., Money, T., Gibbons, A. S., Gillett, P., Dean, B., & Everall, I. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00095 · Cited by 44
Walter, N. T., Markett, S. A., Montag, C., & Reuter, M. (2010) · Social Neuroscience · doi:10.1080/17470919.2010.527169 · Cited by 44
Tunbridge, E. M., Dunn, G., Murray, R. M., Evans, N., Lister, R., Stumpenhorst, K., Harrison, P. J., Morrison, P. D., & Freeman, D. H. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115609073 · Cited by 44
Šagud, M., Tudor, L., Uzun, S., Perković, M. N., Živković, M., Konjevod, M., Kozumplik, O., Ćusa, B. V., Štrac, D. Š., Radoš, I., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00705 · Cited by 44
Lewandowski, K. E. (2007) · Harvard Review of Psychiatry · doi:10.1080/10673220701650409 · Cited by 45
Zannas, A. S., McQuoid, D. R., Steffens, D. C., Chrousos, G. P., & Taylor, W. D. (2012) · Stress · doi:10.3109/10253890.2011.634263 · Cited by 40
Klebe, S., Golmard, J., Nalls, M. A., Saad, M., Singleton, A., Brás, J., Hardy, J., Simón‐Sánchez, J., Heutink, P., Kuhlenbäumer, G., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304475 · Cited by 44
Assessing genetic polymorphisms using DNA extracted from cells present in saliva samples
Nemoda, Z., Horvat‐Gordon, M., Fortunato, C., Beltzer, E. K., Scholl, J. L., & Granger, D. A. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-170 · Cited by 44
Biomarkers for Psychiatric Disorders
Turck, C. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-79251-4 · Cited by 44
Stephens, J. A., Jones, K. T., & Berryhill, M. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-14030-7 · Cited by 43
Perfetti, X., O’Mathúna, B., Pizarro, N., Cuyàs, E., Khymenets, O., Almeida, B., Pellegrini, M., Pichini, S., Lau, S. S., Monks, T. J., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026393 · Cited by 43
Tan, H. Y., Chen, A. G., Chen, Q., Browne, L. B., Verchinski, B. A., Kolachana, B. S., Zhang, F., Apud, J. A., Callicott, J. H., Mattay, V. S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.91 · Cited by 43
Self-citationMeyers, B. L., D’Agostino, A. E., Walker, J., & Kritzer, M. F. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.013 · Cited by 43
Ramsay, H., Kelleher, I., Flannery, P. J., Clarke, M. C., Lynch, F., Harley, M., Connor, D., Fitzpatrick, C., Morris, D. W., & Cannon, M. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079741 · Cited by 43
Liu, J., Gong, P., Gao, X., & Zhou, X. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.005 · Cited by 43
Genetic Factors Modulating the Response to Stimulant Drugs in Humans
Hart, A. B., de Wit, H., & Palmer, A. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_187 · Cited by 43
LUPIEN, S. J., Lord, C., Sindi, S., Wilkinson, C. W., & Fiocco, A. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00097-8 · Cited by 43
Boecker-Schlier, R., Holz, N. E., Buchmann, A. F., Blomeyer, D., Plichta, M. M., Jennen-Steinmetz, C., Wolf, I., Baumeister, S., Treutlein, J., Rietschel, M., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.006 · Cited by 42
Factors Affecting the Absorption, Metabolism, and Excretion of Cocoa Flavanols in Humans
Cifuentes‐Gomez, T., Rodriguez‐Mateos, A., Gonzalez‐Salvador, I., Alañón, M. E., & Spencer, J. P. E. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00443 · Cited by 42
Influence of dopaminergic and serotoninergic genes on working memory in healthy subjects
M.*, W., Hauser, J., Tomaszewska, M., Dmitrzak‐Węglarz, M., Skibińska, M., Szczepankiewicz, A., & Borkowska, A. (2010) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2010-1777 · Cited by 42
Metadata
- Authors
- Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., Egan, M. F., Kleinman, J. E., & Weinberger, D. R.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weinberger, Daniel R.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 75
- Issue
- 5
- Pages
- 807-821
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1182110
- OpenAlex
- W2054856852
- Cited by
- 1,675
- References
- 46
- Citations by year
- 2026: 21 · 2025: 39 · 2024: 47 · 2023: 41 · 2022: 68 · 2021: 76 · 2020: 72 · 2019: 102 · 2018: 73 · 2017: 94 · 2016: 110 · 2015: 110 · 2014: 118 · 2013: 109 · 2012: 103
- FWCI
- 17.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3182 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- catechol-O-methyltransferase, COMT Val158Met polymorphism, single nucleotide polymorphisms, prefrontal cortex, dopamine metabolism, schizophrenia, mRNA expression, protein abundance, postmortem brain, lymphocytes
- MeSH terms
- Analysis of Variance, Animals, Catechol O-Methyltransferase, Genotype, Humans, Lymphocytes, Methylation, Proteins, RNA, Messenger, Sex Factors, Genetic Variation, Blotting, Western, Gene Expression Regulation, Enzymologic, Mutagenesis, Site-Directed, Prefrontal Cortex, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.